#DAX #WallSt Habitually we glance at a company website, when an email request asks us an opinion on a share we’ve not previous looked at. With Nuformix’ website, there was a strong feeling of déjà vu, an almost certainty we’d previously read all their tech bumf. After checking, we found nothing nor had we reported prior to 2017, when known as Levrett Plc. It’s a puzzle.
In our defence, it’s probably a Covid-19 thing, the last 18 months forcing us to review many pharmaceutical concerns with wide ranging expertise. Prior to the pandemic, our main reason for keeping an eye on companies in the drug field, was fuelled by entirely personal reasons, an ongoing ‘battle’ against incurable (but non fatal if treated) leukaemia. The word “battle” is one many folk experiencing chemotherapy prefer avoid, the patient generally an unhappy passenger throughout a process of drugs being used to kill a cancer, preferably without killing the human….
When coming across the term ‘oncology’ when viewing a company website, sometimes the information can be fascinating. Thankfully, Nuformix do not operate in areas of personal interest, thus allowing time to be spent reading without false hope being created for miracle leukaemia cures, promised sometime in the future. It’s easier to be resigned to needing treatment every few years, especially with the added thrill of new drugs provoking interesting and fun new side effects!
Something appears to be happening with Nuformix share price. As the chart below highlights, the share has broken through an obvious downtrend for the last year and is even enjoying a little upward surge, doubtless fuelled by traders who retain a belief in trend breaks proving significant. Trends, while certainly important, unfortunately are more than a line on a chart. Presently trading around 1.65p, we shall regard Nuformix as changing its price trend, if the share price manages to inject itself above just 1.75p. We feel exceeding such a trigger level should be significant, moving the price into a cycle where growth to an initial 2.1p makes a lot of visual sense. Again, as the chart shows, this target level also matches prior highs earlier this year, doubtless expecting some hesitation at such a level.
Should the share price actually CLOSE a session above 2.1p, this is liable to be really important as the Bigger Picture impetus calculates the price as being in a longer term recovery phase to a future 3.05p. Again, the chart agrees such a target level should prove logical. And now, we can also take an unusual step of revealing a third target level at 4p. Quite why the share price can be extrapolated with recovery increments of 1p utterly defeats us! It’s a bit odd and very unusual.
But for now, we suspect Nuformix are worthy of some investigation, especially if it exceeds 1.75p. The price needs drip below 1.2p to justify panic.
Yet again, thanks to those who continue to discover interesting adverts on this page, effectively buying us a coffee with each visit.
FUTURES
| Time Issued | Market | Price At Issue | Short Entry | Fast Exit | Slow Exit | Stop | Long Entry | Fast Exit | Slow Exit | Stop | Prior |
| 10:16:07PM | BRENT | 81.22 | Success | ||||||||
| 10:18:10PM | GOLD | 1773.9 | Success | ||||||||
| 10:20:06PM | FTSE | 7273.08 | Sorry | ||||||||
| 10:23:26PM | FRANCE | 6983 | Success | ||||||||
| 10:27:01PM | GERMANY | 16042 | 15920 | 15892.5 | 15840 | 15982 | 16050 | 16221 | 16422 | 15940 | ‘cess |
| 10:30:15PM | US500 | 4661.22 | Success | ||||||||
| 10:39:11PM | DOW | 36145 | 35970 | 35880 | 35778 | 36056 | 36167 | 36193 | 36295 | 36060 | ‘cess |
| 10:41:13PM | NASDAQ | 16159 | Success | ||||||||
| 10:43:22PM | JAPAN | 29780 | Shambles |
3/11/2021 FTSE Closed at 7248 points. Change of -0.36%. Total value traded through LSE was: £ 5,364,561,051 a change of -4.12%
2/11/2021 FTSE Closed at 7274 points. Change of -0.19%. Total value traded through LSE was: £ 5,594,886,752 a change of 24.19%
1/11/2021 FTSE Closed at 7288 points. Change of 0.7%. Total value traded through LSE was: £ 4,505,252,834 a change of -24.3%
29/10/2021 FTSE Closed at 7237 points. Change of -0.17%. Total value traded through LSE was: £ 5,951,106,978 a change of 27.04%
28/10/2021 FTSE Closed at 7249 points. Change of -0.06%. Total value traded through LSE was: £ 4,684,429,352 a change of -6.92%
27/10/2021 FTSE Closed at 7253 points. Change of -0.33%. Total value traded through LSE was: £ 5,032,708,114 a change of -16.48%
26/10/2021 FTSE Closed at 7277 points. Change of 0.76%. Total value traded through LSE was: £ 6,025,954,185 a change of 32.49%
SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.
Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION
Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.
UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.
We can be contacted at info@trendsandtargets.com. Spam filters set to maximum so only legit emails get through…
Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares
Click Epic to jump to share: LSE:BBY BALFOUR BEATTY** **LSE:CNA Centrica** **LSE:DGE Diageo** **LSE:EXPN Experian** **LSE:FGP Firstgroup** **LSE:IGAS Igas Energy** **LSE:TLW Tullow** **LSE:VOD Vodafone** **
********
Updated charts published on : BALFOUR BEATTY, Centrica, Diageo, Experian, Firstgroup, Igas Energy, Tullow, Vodafone,
LSE:BBY BALFOUR BEATTY Close Mid-Price: 250 Percentage Change: -2.19% Day High: 255.8 Day Low: 249.4
Weakness on BALFOUR BEATTY below 249.4 will invariably lead to 245 with s ……..
</p
View Previous BALFOUR BEATTY & Big Picture ***
LSE:CNA Centrica. Close Mid-Price: 62 Percentage Change: + 0.75% Day High: 63 Day Low: 61.34
Continued trades against CNA with a mid-price ABOVE 63 should improve the ……..
</p
View Previous Centrica & Big Picture ***
LSE:DGE Diageo. Close Mid-Price: 3715 Percentage Change: + 0.04% Day High: 3745 Day Low: 3695.5
Target met. In the event of Diageo enjoying further trades beyond 3745, t ……..
</p
View Previous Diageo & Big Picture ***
LSE:EXPN Experian. Close Mid-Price: 3390 Percentage Change: + 0.06% Day High: 3423 Day Low: 3371
Target met. All Experian needs are mid-price trades ABOVE 3423 to improve ……..
</p
View Previous Experian & Big Picture ***
LSE:FGP Firstgroup. Close Mid-Price: 101.8 Percentage Change: + 0.39% Day High: 103.4 Day Low: 100.7
Further movement against Firstgroup ABOVE 103.4 should improve accelerati ……..
</p
View Previous Firstgroup & Big Picture ***
LSE:IGAS Igas Energy Close Mid-Price: 15.15 Percentage Change: -2.26% Day High: 15.5 Day Low: 14.5
Weakness on Igas Energy below 14.5 will invariably lead to 12.3 next with ……..
</p
View Previous Igas Energy & Big Picture ***
LSE:TLW Tullow Close Mid-Price: 44.4 Percentage Change: -3.27% Day High: 45.43 Day Low: 43.25
Weakness on Tullow below 43.25 will invariably lead to 42 with secondary ……..
</p
View Previous Tullow & Big Picture ***
LSE:VOD Vodafone Close Mid-Price: 106.94 Percentage Change: -1.40% Day High: 108.14 Day Low: 106.3
Weakness on Vodafone below 106.3 will invariably lead to 104 with seconda ……..
</p
View Previous Vodafone & Big Picture ***